Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Procter & Gamble Co (PG) vs SOLAI Limited (SLAI) Price & Performance

Procter & Gamble CoTrade
SOLAI LimitedTrade

Price performance (Past 24H)

Key statistics

Procter & Gamble Co vs SOLAI Limited — how do they compare? Procter & Gamble Co trades at $150.91 (market cap $349.77B), while SOLAI Limited trades at $3.72 (market cap $880.09M). The key difference: Procter & Gamble Co is far larger — about 397.4× SOLAI Limited's market cap, and Procter & Gamble Co pays a 2.89% dividend while SOLAI Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Procter & Gamble Co for 131 Days and SOLAI Limited for 40 Days on average.

PGSLAI
Market Cap
$349.77B$880.09M
Volume
10,055,825122,720
Sector
Consumer StaplesTechnology
52-Week High
$167.18$21.63
52-Week Low
$138.10$2.74
Typical Hold Time
131 Days40 Days
Enterprise Value
$375.61B$879.73M
Dividend Yield
2.89%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Procter & Gamble Co

Procter & Gamble (PG) trades at $147.82, down 0.4% on the day, showing resilience amid market volatility. The stock maintains a bullish technical signal with strong moving average support and has consistently beaten earnings estimates in recent quarters. PG demonstrates robust fundamentals with $84.28B revenue, 18.44% net margin, and steady dividend payments, though valuation multiples remain elevated versus peers.

PG offers stable growth with dividend reliability but faces premium valuation concerns. The 8.3% upside to consensus target of $160.13 suggests moderate potential, while competitive pressures and soft demand outlook present headwinds. Institutional ownership trends show mixed positioning, requiring careful monitoring of margin sustainability and consumer spending patterns.

SOLAI Limited

SLAI trades at $3.72 with no recent price movement. The technical picture is bullish based on moving averages and oscillators, though the stock faces delisting proceedings from the NYSE. Fundamentally, the company shows severe distress with negative gross and net income margins, high revenue decline, and substantial losses despite a low P/B ratio. Recent news highlights governance changes amid exchange compliance issues.

The outlook is highly risky due to financial instability and delisting threat. Investment opportunity exists only for speculative traders betting on a turnaround, given the low valuation multiple. Key risks include continued cash burn, inability to achieve profitability, and loss of major exchange listing impacting liquidity and investor confidence.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PG
91% Buy9% Sell
Avg holding period · 131 Days
SLAI

No sentiment data available yet.

Top news

Latest headlines on both assets

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG →

About SOLAI Limited

SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.

Read more on SLAI →